Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Drug Alcohol Depend. 2015 Nov 12;158:38–44. doi: 10.1016/j.drugalcdep.2015.10.032

Table 5.

Cost-effectiveness analysis—days of abstinence.

Treatment Condition Intervention Cost ($) Societal cost (intervention plus client costs minus savings) ($) Days abstinent during follow-up
TAU (N = 108) 0 1545 (23,195) 590 (201)
TMC (N = 106) 342 (41.52) −838 (11,018) 609 (180)
TMC-plus (N = 107) 561 (39.66) 1497 (20,414) 595 (184)
Cost-effectiveness comparison Incremental intervention cost ($) Incremental societal cost ($) Incremental days abstinent ICER with intervention cost ICER with societal cost
TMC vs. TAU 342 [257, 426] −2,383 [−8,435, 1,565] 18.4 [−39.1, 65.5] 18.6 [4.32, 1030] N/A (TMC dominates)
TMC-plus vs. TAU 561 [488, 639] −47.6 [−5,961, 6,573] 4.23 [−45.7, 53.9] 133 [61.5, 33,959] N/A (TMC-plus dominates)
TMC-plus vs. TMC 219 [103, 329] 2335 [−1260, 8132] −14.2 [−62.1, 32.9] N/A (TMC dominates) N/A (TMC dominates)

Notes: Standard deviations in parentheses. Bootstrapped confidence intervals in brackets.